These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2964329)

  • 1. Microvascular disease and limited joint mobility in diabetes. A comparison of fibrinolysis and prostacyclin in diabetes and systemic sclerosis.
    Larkin JG; Belch JJ; Flanigan P; Forbes CD; Frier BM
    Diabet Med; 1988 Jan; 5(1):53-6. PubMed ID: 2964329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
    Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
    Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications.
    Starkman HS; Gleason RE; Rand LI; Miller DE; Soeldner JS
    Ann Rheum Dis; 1986 Feb; 45(2):130-5. PubMed ID: 3947142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes.
    Arkkila PE; Kantola IM; Viikari JS; Rönnemaa T; Vähätalo MA
    Diabet Med; 1996 Sep; 13(9):828-33. PubMed ID: 8891458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited joint mobility in type 1 diabetic patients: associations with microangiopathy and subclinical macroangiopathy are different in men and women.
    Frost D; Beischer W
    Diabetes Care; 2001 Jan; 24(1):95-9. PubMed ID: 11194249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.
    Hu J; Wei W; Din G; Yuan L; Liu Z
    J Tongji Med Univ; 1998; 18(4):233-5. PubMed ID: 10806853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic retinopathy and its association with limited joint mobility.
    Haitas B; Jones DB; Ting A; Turner RC
    Horm Metab Res; 1986 Nov; 18(11):765-7. PubMed ID: 3792994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-lymphocyte ratio correlates with limited joint mobility of hand in patients with type 2 diabetes.
    Mineoka Y; Ishii M; Hashimoto Y; Nakamura N; Katsumi Y; Isono M; Fukui M
    Endocr J; 2018 Oct; 65(10):1011-1017. PubMed ID: 30012904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited joint mobility in type 1 diabetic patients: correlation to other diabetic complications.
    Arkkila PE; Kantola IM; Viikari JS
    J Intern Med; 1994 Aug; 236(2):215-23. PubMed ID: 8046322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis and diabetic retinopathy.
    Almér LA; Pandolfi M
    Diabetes; 1976; 25(2 SUPPL):807-10. PubMed ID: 61139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
    Morishita E; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Hashimoto T; Matsuda T
    Atherosclerosis; 1996 Feb; 120(1-2):7-14. PubMed ID: 8645373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited finger joint mobility in insulin-dependent and non-insulin-dependent Ethiopian diabetics.
    Mengistu M; Abdulkadir J
    Diabet Med; 1985 Sep; 2(5):387-9. PubMed ID: 2951096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
    Janody D; Droulle C; Adjizian JC; Ostermann G; Poynard JP; Jeunehomme G; Leutenegger M; Potron G
    J Mal Vasc; 1982; 7(3):221-4. PubMed ID: 6815291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous and plasma fibrinolytic activity in systemic sclerosis. Evidence of normal plasminogen activation.
    Matucci-Cerinic M; Lotti T; Lombardi A; Pignone A; Iannone F; Beneforti E; Cinotti S; Morfini M; Caignoni M
    Int J Dermatol; 1990 Nov; 29(9):644-8. PubMed ID: 2125582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited joint mobility of the hand: prevalence and relation to chronic complications in non-insulin-dependent diabetes mellitus patients.
    Lu YC; Wang PW; Liu RT; Tung SC; Chien WY; Hung SL; Chen M
    J Formos Med Assoc; 1993 Feb; 92(2):139-43. PubMed ID: 8101742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited joint mobility in the hands and feet of adolescents with Type 1 diabetes mellitus.
    Duffin AC; Donaghue KC; Potter M; McInnes A; Chan AK; King J; Howard NJ; Silink M
    Diabet Med; 1999 Feb; 16(2):125-30. PubMed ID: 10229305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between limited joint mobility and peripheral nerve function in diabetic children.
    Fiçicioğlu C; Kiziltan M; Aydin A; Baslo P
    Turk J Pediatr; 1996; 38(4):431-7. PubMed ID: 8993172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile diabetes and systemic sclerosis: just a coincidence?
    Mastrangelo G; Meneghel A; Martini G; Moretti C; Zulian F
    Pediatr Rheumatol Online J; 2022 Sep; 20(1):81. PubMed ID: 36089600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.